跳转至内容
Merck
CN

92817

9-氨基吖啶

suitable for matrix substance for MALDI-MS, ≥99.5% (HPLC)

别名:

9-吖啶胺

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C13H10N2
化学文摘社编号:
分子量:
194.23
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
23151816
EC Number:
201-995-6
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

assay

≥99.5% (HPLC)

form

powder

analyte functional class(es)

metabolites

analyte chemical class(es)

lipids

technique(s)

MALDI-MS: suitable

impurities

≤0.05% sulfated ash

loss

≤10% loss on drying

mp

238-240 °C

cation traces

Ba: ≤5 mg/kg, Ca: ≤200 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Fe: ≤10 mg/kg, Li: ≤5 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg, K: ≤100 mg/kg, Na: ≤100 mg/kg

suitability

suitable for matrix substance for MALDI-MS

SMILES string

Nc1c2ccccc2nc3ccccc13

InChI

1S/C13H10N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H,(H2,14,15)

InChI key

XJGFWWJLMVZSIG-UHFFFAOYSA-N

General description

9-氨基吖啶,一种氨基吖啶染料,可作为病毒和细菌的有效诱变剂。

Application

MALDI 基质在在负模式下分析低分子量阴离子(如代谢物)时具有背景低和灵敏度好的特点


Still not finding the right product?

Explore all of our products under 9-氨基吖啶


pictograms

Exclamation markEnvironment

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Mutagen-nucleic acid intercalative binding: structure of a 9-aminoacridine: 5-iodocytidylyl (3'-5') guanosine crystalline complex.
Sakore, T. D., et al.
Proceedings of the National Academy of Sciences of the USA, 74.1, 188-192 (1977)
9-Aminoacridine as a matrix for negative mode matrix-assisted laser desorption/ionization
Vermillion-Salsbury, R. L. and Hercules, D. M.
Rapid Communications in Mass Spectrometry, 16, 1575-1581 (2002)
Daniel J Karst et al.
Biotechnology progress, 33(4), 879-890 (2016-12-21)
Perfusion cell culture processes allow the steady-state culture of mammalian cells at high viable cell density, which is beneficial for overall product yields and homogeneity of product quality in the manufacturing of therapeutic proteins. In this study, the extent of



全球贸易项目编号

货号GTIN
92817-1G04061833270394